Follow
Ines Bártolo
Ines Bártolo
iMedULisboa
Verified email at ff.ulisboa.pt
Title
Cited by
Cited by
Year
Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance
X Deng, A Achari, S Federman, G Yu, S Somasekar, I Bártolo, S Yagi, ...
Nature microbiology 5 (3), 443-454, 2020
1412020
Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic
I Bártolo, C Rocha, J Bartolomeu, A Gama, R Marcelino, M Fonseca, ...
Infection, Genetics and Evolution 9 (4), 672-682, 2009
702009
Baseline susceptibility of primary HIV-2 to entry inhibitors
P Borrego, R Calado, JM Marcelino, I Bártolo, C Rocha, P Cavaco-Silva, ...
Antiviral therapy 17 (3), 565-570, 2012
632012
Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus …
R Antunes, S Figueiredo, I Bártolo, M Pinheiro, L Rosado, I Soares, ...
Journal of clinical microbiology 41 (7), 3361-3367, 2003
592003
Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection
H Barroso, P Borrego, I Bártolo, JM Marcelino, C Família, A Quintas, ...
PloS one 6 (1), e14548, 2011
472011
High genetic diversity of human immunodeficiency virus type 1 in Angola
I Bártolo, M Epalanga, J Bartolomeu, M Fonseca, A Mendes, A Gama, ...
AIDS Research & Human Retroviruses 21 (4), 306-310, 2005
452005
Origin and epidemiological history of HIV-1 CRF14_BG
I Bartolo, AB Abecasis, P Borrego, H Barroso, F McCutchan, P Gomes, ...
PLoS One 6 (9), e24130, 2011
372011
HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique
I Bártolo, J Casanovas, R Bastos, C Rocha, AB Abecasis, E Folgosa, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (3), 323-331, 2009
362009
Keratinocyte growth factor-based strategies for wound re-epithelialization
I Bártolo, RL Reis, AP Marques, MT Cerqueira
Tissue Engineering Part B: Reviews 28 (3), 665-676, 2022
322022
Noncovalent PEG coating of nanoparticle drug carriers improves the local pharmacokinetics of rectal anti-HIV microbicides
R Nunes, F Araujo, L Barreiros, I Bartolo, MA Segundo, N Taveira, ...
ACS applied materials & interfaces 10 (41), 34942-34953, 2018
312018
Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug …
I Bártolo, C Rocha, J Bartolomeu, A Gama, M Fonseca, A Mendes, ...
Antimicrobial agents and chemotherapy 53 (7), 3156-3158, 2009
312009
HIV-1 diversity, transmission dynamics and primary drug resistance in Angola
I Bártolo, S Zakovic, F Martin, C Palladino, P Carvalho, R Camacho, ...
PloS one 9 (12), e113626, 2014
292014
Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity
O Adeoye, I Bártolo, J Conceiçăo, AB da Silva, N Duarte, AP Francisco, ...
International Journal of Pharmaceutics 583, 119356, 2020
272020
Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique
C Palladino, V Briz, JM Bellón, I Bartolo, P Carvalho, R Camacho, ...
PLoS One 8 (12), e82718, 2013
272013
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
C Rocha, R Calado, P Borrego, JM Marcelino, I Bártolo, L Rosado, ...
Retrovirology 10, 1-14, 2013
252013
Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and Plasmodium
NG Alves, I Bártolo, AJS Alves, D Fontinha, D Francisco, SMM Lopes, ...
European Journal of Medicinal Chemistry 219, 113439, 2021
232021
Spiro-lactams as novel antimicrobial agents
AJS Alves, NG Alves, CC Caratăo, MIM Esteves, D Fontinha, I Bártolo, ...
Current Topics in Medicinal Chemistry 20 (2), 140-152, 2020
212020
Seronegative infection and AIDS caused by an A2 subsubtype HIV-1
AR Cardoso, C Gonçalves, D Pascoalinho, C Gil, AF Ferreira, I Bártolo, ...
Aids 18 (7), 1071-1074, 2004
182004
Antiretroviral treatment of HIV-2 infection: available drugs, resistance pathways, and promising new compounds
I Moranguinho, N Taveira, I Bártolo
International Journal of Molecular Sciences 24 (6), 5905, 2023
172023
On the contribution of Angola to the initial spread of HIV-1
AC Pineda-Peńa, J Varanda, JD Sousa, K Theys, I Bártolo, T Leitner, ...
Infection, Genetics and Evolution 46, 219-222, 2016
172016
The system can't perform the operation now. Try again later.
Articles 1–20